$27.37
-1.53-5.29%
Last update: Oct 1, 5:53 PM
$28.40
-0.50-1.73%
Adaptive Biotechnologies Corp
ADPTNASDAQ
Adaptive Biotechnologies (ADPT) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
Adaptive Biotechnologies (ADPT) last issued guidance on January 12, 2026 for fiscal year 2025. The company guided revenue in the range of $277M - $277M for the period.
Compared to prior guidance, Adaptive Biotechnologies raised its revenue forecast from a prior range of $72M - $72M.
Adaptive Biotechnologies has issued 9 guidance updates between November 3, 2022 and January 12, 2026. During this period, the company raised its outlook 4 times and lowered it 2 times, providing investors with insight into management's evolving expectations.
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.13 | $-0.16 | $-0.19 | $-0.15 |
| Actual | $-0.10 | $-0.13 | $-0.09 | $-0.15 |
| Surprise | +23.1% | +18.8% | +52.6% | 0.00% |
| Revenue | ||||
| Estimate | $66.1M | $61.1M | $60.9M | $66.0M |
| Actual | $71.6M | $70.9M | $71.7M | $60.2M |
| Surprise | +8.29% | +16.1% | +17.7% | -8.78% |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.10 | $-0.07 | $-0.08 | $-0.05 |
| Revenue | ||||
| Consensus | $71.8M | $79.1M | — | — |
| Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $-0.10 | $-0.13 | 23.1 % |
| Q1 | May 5, 2026 | $-0.13 | $-0.16 | 18.8 % |
| Q4 | Feb 5, 2026 | $-0.09 | $-0.19 | 52.6 % |
| Q3 | Nov 5, 2025 | $-0.15 | $-0.15 | 0.00 % |
| Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Q2 | Jul 29, 2026 | $71.55M | $66.08M | 8.29 % |
| Q1 | May 5, 2026 | $70.87M | $61.07M | 16.1 % |
| Q4 | Feb 5, 2026 | $71.68M | $60.90M | 17.7 % |
| Q3 | Nov 5, 2025 | $60.20M | $66.00M | -8.78 % |
